BioCorRx Completes $940,000 Equity Financing and Announces Alpine Creek Capital has Agreed to Invest an Additional $1.7 Million Mar 10, 2017
BioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products Jan 12, 2017
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA Nov 28, 2016
BioCorRx Inc. to Host Corporate Update Webinar on Wednesday, October 12th at 2:00 p.m. Eastern Time Oct 6, 2016
BioCorRx Inc. to Present at the Singular Research 11th Annual Best of the Uncovereds Investment Conference September 22nd Sep 19, 2016
